| Description | LBM-415 is a peptide deformylase (PDF) inhibitor. |
| Synonyms | NVP-PDF-713 |
| molecular weight | 396.41 |
| Molecular formula | C18H25FN4O5 |
| CAS | 478913-91-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Sangshetti JN, Khan FA, Shinde DB. Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery. Curr Med Chem. 2015;22(2):214-36. Review. PubMed PMID: 25174923. 2. Yu L, Zhou W, Wang Z. Synthesis and in vitro antibacterial activity of oxazolidine LBM-415 analogs as peptide deformylase inhibitors. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1541-4. doi: 10.1016/j.bmcl.2010.12.097. Epub 2010 Dec 24. PubMed PMID: 21288715. 3. Wang Z, Zhou W. Synthesis and in vitro antibacterial activity of (2S)-N-(substitutedphenyl)-1-[(2R)-2-[(formylhydroxyamino)methyl]-1-oxohexyl]-2-p yrrolidinecarboxamides as potential peptide deformylase inhibitors. Chem Biol Drug Des. 2009 Jan;73(1):142-6. doi: 10.1111/j.1747-0285.2008.00753.x. PubMed PMID: 19152643. 4. Guay DR. Drug forecast - the peptide deformylase inhibitors as antibacterial agents. Ther Clin Risk Manag. 2007 Aug;3(4):513-25. PubMed PMID: 18472972; PubMed Central PMCID: PMC2374925. |